{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["anticancer", "chemotherapy", "herb-derived compounds", "nanoparticles", "pharmacokinetics", "traditional medicines"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "31632004", "DateCompleted": {"Year": "2019", "Month": "12", "Day": "13"}, "DateRevised": {"Year": "2019", "Month": "12", "Day": "17"}, "Article": {"ArticleDate": [{"Year": "2019", "Month": "07", "Day": "23"}], "Language": ["eng"], "ELocationID": ["10.2147/IJN.S213229"], "Journal": {"ISSN": "1178-2013", "JournalIssue": {"Volume": "14", "PubDate": {"Year": "2019"}}, "Title": "International journal of nanomedicine", "ISOAbbreviation": "Int J Nanomedicine"}, "ArticleTitle": "Pharmacokinetic studies of nanoparticles as a delivery system for conventional drugs and herb-derived compounds for cancer therapy: a systematic review.", "Pagination": {"StartPage": "5659", "EndPage": "5677", "MedlinePgn": "5659-5677"}, "Abstract": {"AbstractText": ["The poor pharmacokinetic characteristics of most anticancer drugs have limited their clinical effectiveness. The application of nanoparticles as a novel drug delivery system has provided opportunities to tackle the current challenges facing conventional drug delivery systems such as poor pharmacokinetics, lack of specificity to tumor cells, multidrug resistance, and toxicity. This systematic review aims to examine the application of pharmacokinetic studies of nanoparticles loaded in conventional drugs and herb-derived compounds for cancer therapy. The pharmacokinetic parameters of several herbal medicines and chemotherapeutic drugs loaded into nanoparticles were reported. This included area under the curve (AUC) of plasma concentration-time profile, maximum plasma concentration (C<sub>max</sub>), time to maximum plasma concentration (T<sub>max</sub>), volume of distribution (V<sub>d</sub> or V<sub>ss</sub>), elimination half-life (t<sub>\u00bd</sub>), and clearance (CL). The systematic review was conducted using information available in the PubMed and Science Direct databases up to February 2019. The search terms employed were: pharmacokinetics, pharmacokinetic study, nanoparticles, anticancer, traditional medicine, herbal medicine, herb-derived compounds, natural products, and chemotherapy. Overall, nanoparticle carriers not only significantly improved pharmacokinetics but also further enhanced permeability, solubility, stability, specificity, and selectivity of the carried anticancer drugs/herb-derived compounds to target tumor cells. Additionally, they also limited hepatic first-pass metabolism and P-glycoprotein (P-gp) efflux of the carried anticancer drugs/herb-derived compounds. Based on this systematic review, polymeric nanoparticles were the most commonly used nanocarrier to improve the pharmacokinetic parameters. The use of nanoparticles as a novel drug delivery system has the potential to improve both pharmacokinetics and cytotoxicity activity of the loaded drugs/herb-derived compounds for cancer therapy."], "CopyrightInformation": "\u00a9 2019 Abdifetah and Na-Bangchang."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Graduate Studies, Chulabhorn International College of Medicine, Thammasat University, Pathumthani, Thailand."}, {"Identifier": [], "Affiliation": "Center of Excellence in Pharmacology and Molecular Biology of Malaria and Cholangiocarcinoma, Chulabhorn International College of Medicine, Thammasat University, Pathumthani, Thailand."}], "LastName": "Abdifetah", "ForeName": "Omar", "Initials": "O"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Graduate Studies, Chulabhorn International College of Medicine, Thammasat University, Pathumthani, Thailand."}, {"Identifier": [], "Affiliation": "Center of Excellence in Pharmacology and Molecular Biology of Malaria and Cholangiocarcinoma, Chulabhorn International College of Medicine, Thammasat University, Pathumthani, Thailand."}, {"Identifier": [], "Affiliation": "Drug Discovery Center, Thammasat University, Pathumthani, Thailand."}], "LastName": "Na-Bangchang", "ForeName": "Kesara", "Initials": "K"}], "PublicationTypeList": ["Journal Article", "Systematic Review"]}, "MedlineJournalInfo": {"Country": "New Zealand", "MedlineTA": "Int J Nanomedicine", "NlmUniqueID": "101263847", "ISSNLinking": "1176-9114"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["administration & dosage", "pharmacokinetics"], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": [], "DescriptorName": "Drug Delivery Systems"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["chemistry"], "DescriptorName": "Nanoparticles"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Neoplasms"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}], "CoiStatement": "The authors report no conflicts of interest in this work."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Feng -S-S, Zhao L, Zhang Z, et al. Chemotherapeutic engineering: vitamin E TPGS-emulsified nanoparticles of biodegradable polymers realized sustainable paclitaxel chemotherapy for 168h in vivo. Chem Eng Sci. 2007;62(23):6641\u20136648. doi:10.1016/j.ces.2007.08.006", "ArticleIdList": ["10.1016/j.ces.2007.08.006"]}, {"Citation": "Rafiei P, Haddadi A. Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile. Int J Nanomedicine. 2017;12:935\u2013947. doi:10.2147/IJN.S121881", "ArticleIdList": ["10.2147/IJN.S121881", "PMC5291330", "28184163"]}, {"Citation": "Vardhan H, Mittal P, Adena SKR, Upadhyay M, Mishra B. Development of long-circulating docetaxel loaded poly (3-hydroxybutyrate-co-3-hydroxyvalerate) nanoparticles: optimization, pharmacokinetic, cytotoxicity and in vivo assessments. Int J Biol Macromol. 2017;103:791\u2013801. doi:10.1016/j.ijbiomac.2017.05.125", "ArticleIdList": ["10.1016/j.ijbiomac.2017.05.125", "28536023"]}, {"Citation": "Zabaleta V, Ponchel G, Salman H, Agueros M, Vauthier C, Irache JM. Oral administration of paclitaxel with pegylated poly(anhydride) nanoparticles: permeability and pharmacokinetic study. Eur J Pharm Biopharm. 2012;81(3):514\u2013523. doi:10.1016/j.ejpb.2012.04.001", "ArticleIdList": ["10.1016/j.ejpb.2012.04.001", "22516136"]}, {"Citation": "Qiao H, Li J, Wang Y, Ping Q, Wang G, Gu X. Synthesis and characterization of multi-functional linear-dendritic block copolymer for intracellular delivery of antitumor drugs. Int J Pharm. 2013;452(1\u20132):363\u2013373. doi:10.1016/j.ijpharm.2013.05.003", "ArticleIdList": ["10.1016/j.ijpharm.2013.05.003", "23680725"]}, {"Citation": "Saremi S, Dinarvand R, Kebriaeezadeh A, Ostad SN, Atyabi F. Enhanced oral delivery of docetaxel using thiolated chitosan nanoparticles: preparation, in vitro and in vivo studies. Biomed Res Int. 2013;2013:150478. doi:10.1155/2013/150478", "ArticleIdList": ["10.1155/2013/150478", "PMC3736506", "23971023"]}, {"Citation": "Lee JY, Kim JS, Cho HJ, Kim DD. Poly(styrene)-b-poly(DL-lactide) copolymer-based nanoparticles for anticancer drug delivery. Int J Nanomedicine. 2014;9:2803\u20132813. doi:10.2147/IJN.S62806", "ArticleIdList": ["10.2147/IJN.S62806", "PMC4051715", "24940058"]}, {"Citation": "Bernabeu E, Helguera G, Legaspi MJ, et al. Paclitaxel-loaded PCL-TPGS nanoparticles: in vitro and in vivo performance compared with Abraxane(R). Colloids Surf B Biointerfaces. 2014;113:43\u201350. doi:10.1016/j.colsurfb.2013.07.036", "ArticleIdList": ["10.1016/j.colsurfb.2013.07.036", "24060929"]}, {"Citation": "Ernsting MJ, Tang WL, MacCallum NW, Li SD. Preclinical pharmacokinetic, biodistribution, and anti-cancer efficacy studies of a docetaxel-carboxymethylcellulose nanoparticle in mouse models. Biomaterials. 2012;33(5):1445\u20131454. doi:10.1016/j.biomaterials.2011.10.061", "ArticleIdList": ["10.1016/j.biomaterials.2011.10.061", "22079003"]}, {"Citation": "Ho KS, Aman AM, Al-awar RS, Shoichet MS. Amphiphilic micelles of poly(2-methyl-2-carboxytrimethylene carbonate-co-D,L-lactide)-graft-poly(ethylene glycol) for anti-cancer drug delivery to solid tumours. Biomaterials. 2012;33(7):2223\u20132229. doi:10.1016/j.biomaterials.2011.11.072", "ArticleIdList": ["10.1016/j.biomaterials.2011.11.072", "22182751"]}, {"Citation": "Khurana RK, Beg S, Burrow AJ, et al. Enhancing biopharmaceutical performance of an anticancer drug by long chain PUFA based self-nanoemulsifying lipidic nanomicellar systems. Eur J Pharm Biopharm. 2017;121:42\u201360. doi:10.1016/j.ejpb.2017.09.001", "ArticleIdList": ["10.1016/j.ejpb.2017.09.001", "28887099"]}, {"Citation": "Yu Y, Tan S, Zhao S, et al. Antitumor activity of docetaxel-loaded polymeric nanoparticles fabricated by Shirasu porous glass membrane-emulsification technique. Int J Nanomedicine. 2013;8:2641\u20132652. doi:10.2147/IJN.S48214", "ArticleIdList": ["10.2147/IJN.S48214", "PMC3735276", "23935362"]}, {"Citation": "Senthilkumar M, Mishra P, Jain NK. Long circulating PEGylated poly(D,L-lactide-co-glycolide) nanoparticulate delivery of Docetaxel to solid tumors. J Drug Target. 2008;16(5):424\u2013435. doi:10.1080/10611860802088598", "ArticleIdList": ["10.1080/10611860802088598", "18569287"]}, {"Citation": "Chao Y, Liang Y, Fang G, et al. Biodegradable polymersomes as nanocarriers for doxorubicin hydrochloride: enhanced cytotoxicity in MCF-7/ADR cells and prolonged blood circulation. Pharm Res. 2017;34(3):610\u2013618. doi:10.1007/s11095-016-2088-9", "ArticleIdList": ["10.1007/s11095-016-2088-9", "28004317"]}, {"Citation": "Guo Y, Chu M, Tan S, et al. Chitosan-g-TPGS nanoparticles for anticancer drug delivery and overcoming multidrug resistance. Mol Pharm. 2014;11(1):59\u201370. doi:10.1021/mp400514t", "ArticleIdList": ["10.1021/mp400514t", "24229050"]}, {"Citation": "Kalaria DR, Sharma G, Beniwal V, Ravi Kumar MN. Design of biodegradable nanoparticles for oral delivery of doxorubicin: in vivo pharmacokinetics and toxicity studies in rats. Pharm Res. 2009;26(3):492\u2013501. doi:10.1007/s11095-008-9763-4", "ArticleIdList": ["10.1007/s11095-008-9763-4", "18998202"]}, {"Citation": "Jain A, Agarwal A, Majumder S, et al. Mannosylated solid lipid nanoparticles as vectors for site-specific delivery of an anti-cancer drug. J Control Release. 2010;148(3):359\u2013367. doi:10.1016/j.jconrel.2010.09.003", "ArticleIdList": ["10.1016/j.jconrel.2010.09.003", "20854859"]}, {"Citation": "Zhang W, Sun J, Liu Y, et al. PEG-stabilized bilayer nanodisks as carriers for doxorubicin delivery. Mol Pharm. 2014;11(10):3279\u20133290. doi:10.1021/mp400566a", "ArticleIdList": ["10.1021/mp400566a", "24754897"]}, {"Citation": "Lee JY, Park JH, Lee JJ, et al. Polyethylene glycol-conjugated chondroitin sulfate A derivative nanoparticles for tumor-targeted delivery of anticancer drugs. Carbohydr Polym. 2016;151:68\u201377. doi:10.1016/j.carbpol.2016.05.043", "ArticleIdList": ["10.1016/j.carbpol.2016.05.043", "27474544"]}, {"Citation": "Yu JM, Li YJ, Qiu LY, Jin Y. Polymeric nanoparticles of cholesterol-modified glycol chitosan for doxorubicin delivery: preparation and in-vitro and in-vivo characterization. J Pharm Pharmacol. 2009;61(6):713\u2013719. doi:10.1211/jpp.61.06.0003", "ArticleIdList": ["10.1211/jpp.61.06.0003", "19505361"]}, {"Citation": "Agarwal A, Gupta U, Asthana A, Jain NK. Dextran conjugated dendritic nanoconstructs as potential vectors for anti-cancer agent. Biomaterials. 2009;30(21):3588\u20133596. doi:10.1016/j.biomaterials.2009.03.016", "ArticleIdList": ["10.1016/j.biomaterials.2009.03.016", "19344947"]}, {"Citation": "Ahmad N, Ahmad R, Alam MA, et al. Daunorubicin oral bioavailability enhancement by surface coated natural biodegradable macromolecule chitosan based polymeric nanoparticles. Int J Biol Macromol. 2019;128:825\u2013838. doi:10.1016/j.ijbiomac.2019.01.142", "ArticleIdList": ["10.1016/j.ijbiomac.2019.01.142", "30690115"]}, {"Citation": "Varghese SE, Fariya MK, Rajawat GS, Steiniger F, Fahr A, Nagarsenker MS. Lecithin and PLGA-based self-assembled nanocomposite, Lecithmer: preparation, characterization, and pharmacokinetic/pharmacodynamic evaluation. Drug Deliv Transl Res. 2016;6(4):342\u2013353. doi:10.1007/s13346-016-0314-y", "ArticleIdList": ["10.1007/s13346-016-0314-y", "27371394"]}, {"Citation": "Li S, Wang A, Jiang W, Guan Z. Pharmacokinetic characteristics and anticancer effects of 5-fluorouracil loaded nanoparticles. BMC Cancer. 2008;8:103. doi:10.1186/1471-2407-8-172", "ArticleIdList": ["10.1186/1471-2407-8-172", "PMC2375900", "18412945"]}, {"Citation": "Kim YH, Lee SJ, Lee SH, Hahn M. Preclinical efficacy and safety assessment of nano-oxaliplatin oral formulation prepared by novel Fat Employing Supercritical Nano System, the FESNS(R). Pharm Dev Technol. 2012;17(6):677\u2013686. doi:10.3109/10837450.2011.565349", "ArticleIdList": ["10.3109/10837450.2011.565349", "23216046"]}, {"Citation": "Kumar R, Kumar P, Singh B, et al. In vivo pharmacokinetic studies and intracellular delivery of methotrexate by means of glycine-tethered PLGA-based polymeric micelles. Int J Pharm. 2017;519(1\u20132):138\u2013144. doi:10.1016/j.ijpharm.2017.01.021", "ArticleIdList": ["10.1016/j.ijpharm.2017.01.021", "28093326"]}, {"Citation": "Zhang H, Wu F, Li Y, et al. Chitosan-based nanoparticles for improved anticancer efficacy and bioavailability of mifepristone. Beilstein J Nanotechnol. 2016;7:1861\u20131870. doi:10.3762/bjnano.7.178", "ArticleIdList": ["10.3762/bjnano.7.178", "PMC5238647", "28144535"]}, {"Citation": "Khare V, Singh A, Mahajan G, et al. Long-circulatory nanoparticles for gemcitabine delivery: development and investigation of pharmacokinetics and in-vivo anticancer efficacy. Eur J Pharm Sci. 2016;92:183\u2013193. doi:10.1016/j.ejps.2016.07.007", "ArticleIdList": ["10.1016/j.ejps.2016.07.007", "27404580"]}, {"Citation": "Shavi GV, Nayak UY, Maliyakkal N, et al. Nanomedicine of anastrozole for breast cancer: physicochemical evaluation, in vitro cytotoxicity on BT-549 and MCF-7 cell lines and preclinical study on rat model. Life Sci. 2015;141:143\u2013155. doi:10.1016/j.lfs.2015.09.021", "ArticleIdList": ["10.1016/j.lfs.2015.09.021", "26423561"]}, {"Citation": "Andey T, Sudhakar G, Marepally S, Patel A, Banerjee R, Singh M. Lipid nanocarriers of a lipid-conjugated estrogenic derivative inhibit tumor growth and enhance cisplatin activity against triple-negative breast cancer: pharmacokinetic and efficacy evaluation. Mol Pharm. 2015;12(4):1105\u20131120. doi:10.1021/mp5008629", "ArticleIdList": ["10.1021/mp5008629", "25661724"]}, {"Citation": "Shalaby KS, Soliman ME, Bonacucina G, et al. Nanoparticles based on linear and star-shaped poly(ethylene glycol)-poly(epsilon-caprolactone) copolymers for the delivery of antitubulin drug. Pharm Res. 2016;33(8):2010\u20132024. doi:10.1007/s11095-016-1939-8", "ArticleIdList": ["10.1007/s11095-016-1939-8", "27177721"]}, {"Citation": "Woo HN, Chung HK, Ju EJ, et al. Preclinical evaluation of injectable sirolimus formulated with polymeric nanoparticle for cancer therapy. Int J Nanomedicine. 2012;7:2197\u20132208. doi:10.2147/IJN.S29480", "ArticleIdList": ["10.2147/IJN.S29480", "PMC3356221", "22619555"]}, {"Citation": "Sharma AK, Gupta L, Sahu H, et al. Chitosan engineered PAMAM dendrimers as nanoconstructs for the enhanced anti-cancer potential and improved in vivo brain pharmacokinetics of temozolomide. Pharm Res. 2018;35(1):9. doi:10.1007/s11095-017-2324-y", "ArticleIdList": ["10.1007/s11095-017-2324-y", "29294212"]}, {"Citation": "Shukla M, Jaiswal S, Sharma A, et al. A combination of complexation and self-nanoemulsifying drug delivery system for enhancing oral bioavailability and anticancer efficacy of curcumin. Drug Dev Ind Pharm. 2017;43(5):847\u2013861. doi:10.1080/03639045.2016.1239732", "ArticleIdList": ["10.1080/03639045.2016.1239732", "27648633"]}, {"Citation": "Chaurasia S, Chaubey P, Patel RR, Kumar N, Mishra B. Curcumin-polymeric nanoparticles against colon-26 tumor-bearing mice: cytotoxicity, pharmacokinetic and anticancer efficacy studies. Drug Dev Ind Pharm. 2016;42(5):694\u2013700. doi:10.3109/03639045.2015.1064941", "ArticleIdList": ["10.3109/03639045.2015.1064941", "26165247"]}, {"Citation": "Lollo G, Ullio-Gamboa G, Fuentes E, Matha K, Lautram N, Benoit JP. In vitro anti-cancer activity and pharmacokinetic evaluation of curcumin-loaded lipid nanocapsules. Mater Sci Eng C Mater Biol Appl. 2018;91:859\u2013867. doi:10.1016/j.msec.2018.06.014", "ArticleIdList": ["10.1016/j.msec.2018.06.014", "30033321"]}, {"Citation": "Ramaswamy S, Dwarampudi LP, Kadiyala M, et al. Formulation and characterization of chitosan encapsulated phytoconstituents of curcumin and rutin nanoparticles. Int J Biol Macromol. 2017;104:1807\u20131812. doi:10.1016/j.ijbiomac.2017.06.112", "ArticleIdList": ["10.1016/j.ijbiomac.2017.06.112", "28668610"]}, {"Citation": "Song Z, Zhu W, Song J, et al. Linear-dendrimer type methoxy-poly (ethylene glycol)-b-poly (epsilon-caprolactone) copolymer micelles for the delivery of curcumin. Drug Deliv. 2015;22(1):58\u201368. doi:10.3109/10717544.2014.901436", "ArticleIdList": ["10.3109/10717544.2014.901436", "24725028"]}, {"Citation": "Yoon IS, Park JH, Kang HJ, et al. Poly(D,L-lactic acid)-glycerol-based nanoparticles for curcumin delivery. Int J Pharm. 2015;488(1\u20132):70\u201377. doi:10.1016/j.ijpharm.2015.04.046", "ArticleIdList": ["10.1016/j.ijpharm.2015.04.046", "25900098"]}, {"Citation": "Yang X, Liu Y, Zhao Y, et al. A stabilizer-free and organic solvent-free method to prepare 10-hydroxycamptothecin nanocrystals: in vitro and in vivo evaluation. Int J Nanomedicine. 2016;11:2979\u20132994. doi:10.2147/IJN.S102726", "ArticleIdList": ["10.2147/IJN.S102726", "PMC4922823", "27382284"]}, {"Citation": "Wang A, Li S. Hydroxycamptothecin-loaded nanoparticles enhance target drug delivery and anticancer effect. BMC Biotechnol. 2008;8:46. doi:10.1186/1472-6750-8-46", "ArticleIdList": ["10.1186/1472-6750-8-46", "PMC2386803", "18454874"]}, {"Citation": "Padhi S, Kapoor R, Verma D, Panda AK, Iqbal Z. Formulation and optimization of topotecan nanoparticles: in vitro characterization, cytotoxicity, cellular uptake and pharmacokinetic outcomes. J Photochem Photobiol B. 2018;183:222\u2013232. doi:10.1016/j.jphotobiol.2018.04.022", "ArticleIdList": ["10.1016/j.jphotobiol.2018.04.022", "29729631"]}, {"Citation": "Du Y, Ling L, Ismail M, et al. Redox sensitive lipid-camptothecin conjugate encapsulated solid lipid nanoparticles for oral delivery. Int J Pharm. 2018;549(1\u20132):352\u2013362. doi:10.1016/j.ijpharm.2018.08.010", "ArticleIdList": ["10.1016/j.ijpharm.2018.08.010", "30099214"]}, {"Citation": "Hao L, Wang X, Zhang D, et al. Studies on the preparation, characterization and pharmacokinetics of Amoitone B nanocrystals. Int J Pharm. 2012;433(1\u20132):157\u2013164. doi:10.1016/j.ijpharm.2012.05.002", "ArticleIdList": ["10.1016/j.ijpharm.2012.05.002", "22579996"]}, {"Citation": "Jin X, Zhang ZH, Sun E, et al. Enhanced oral absorption of 20(S)-protopanaxadiol by self-assembled liquid crystalline nanoparticles containing piperine: in vitro and in vivo studies. Int J Nanomedicine. 2013;8:641\u2013652. doi:10.2147/IJN.S38203", "ArticleIdList": ["10.2147/IJN.S38203", "PMC3576041", "23426652"]}, {"Citation": "Wang L, Luo Q, Lin T, et al. PEGylated nanostructured lipid carriers (PEG-NLC) as a novel drug delivery system for biochanin A. Drug Dev Ind Pharm. 2015;41(7):1204\u20131212. doi:10.3109/03639045.2014.938082", "ArticleIdList": ["10.3109/03639045.2014.938082", "25010850"]}, {"Citation": "Freag MS, Saleh WM, Abdallah OY. Self-assembled phospholipid-based phytosomal nanocarriers as promising platforms for improving oral bioavailability of the anticancer celastrol. Int J Pharm. 2018;535(1\u20132):18\u201326. doi:10.1016/j.ijpharm.2017.10.053", "ArticleIdList": ["10.1016/j.ijpharm.2017.10.053", "29102699"]}, {"Citation": "Liu TT, Mu LQ, Dai W, Wang CB, Liu XY, Xiang DX. Preparation, characterization, and evaluation of antitumor effect of Brucea javanica oil cationic nanoemulsions. Int J Nanomedicine. 2016;11:2515\u20132529. doi:10.2147/IJN.S101918", "ArticleIdList": ["10.2147/IJN.S101918", "PMC4898033", "27330293"]}, {"Citation": "Zhang T, Wang H, Ye Y, Zhang X, Wu B. Micellar emulsions composed of mPEG-PCL/MCT as novel nanocarriers for systemic delivery of genistein: a comparative study with micelles. Int J Nanomedicine. 2015;10:6175\u20136184. doi:10.2147/IJN.S91348", "ArticleIdList": ["10.2147/IJN.S91348", "PMC4598212", "26491290"]}, {"Citation": "Gao Y, Qi X, Zheng Y, et al. Nanoemulsion enhances alpha-tocopherol succinate bioavailability in rats. Int J Pharm. 2016;515(1\u20132):506\u2013514. doi:10.1016/j.ijpharm.2016.10.026", "ArticleIdList": ["10.1016/j.ijpharm.2016.10.026", "27746330"]}]}], "History": [{"Year": "2019", "Month": "4", "Day": "23"}, {"Year": "2019", "Month": "5", "Day": "31"}, {"Year": "2019", "Month": "10", "Day": "22", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "10", "Day": "22", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "12", "Day": "18", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "7", "Day": "23"}], "PublicationStatus": "epublish", "ArticleIdList": ["31632004", "PMC6781664", "10.2147/IJN.S213229", "213229"]}}]}